News from celsion corporation A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Nov 11, 2014, 08:00 ET

Celsion Corporation Reports Third Quarter 2014 Financial Results

 Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced financial results for the third quarter ended...

Nov 05, 2014, 08:00 ET

Celsion Corporation Receives VHP Approval to Initiate OPTIMA Study in Europe

Celsion Corporation (NASDAQ: CLSN) announced today that the Phase III OPTIMA Study was approved via Europe's centralized Voluntary Harmonization...

Nov 04, 2014, 08:00 ET

Celsion Corporation to Hold Third Quarter 2014 Financial Results Conference Call on Tuesday, November 11, 2014

 Celsion Corporation (NASDAQ: CLSN) announced today that the Company will host a conference call to discuss its third quarter 2014 financial...

Oct 29, 2014, 08:00 ET

Celsion Presents Preclinical Data for its TheraSilence™ Platform at the miRNA World Conference Workshop on miRNA Delivery

 Celsion Corporation (NASDAQ: CLSN) today announced the presentation of data related to TheraSilence™, the Company's lung-specific RNA...

Oct 07, 2014, 17:00 ET

Celsion Announces Appointment of Michael H. Tardugno to Executive Chairman of the Board of Directors

 Celsion Corporation (NASDAQ: CLSN) announced that the Board of Directors has appointed Michael H. Tardugno, the Company's President and CEO,...

Oct 07, 2014, 16:35 ET

Celsion Announces The Unexpected Passing of Max E. Link, Ph.D., Chairman of the Board

 Celsion Corporation (NASDAQ: CLSN) is saddened to announce the passing of Max E. Link, Ph.D., a Director and the Chairman of the Board of...

Sep 08, 2014, 08:00 ET

Celsion Announces Highlights from Three Presentations Given at the International Liver Cancer Association 2014 Annual Conference

 Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced highlights from three presentations by...

Sep 04, 2014, 09:05 ET
Sep 02, 2014, 08:00 ET

Celsion Announces Enrollment of First Patient in Global Phase III OPTIMA Study of ThermoDox® in Primary Liver Cancer

Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced that the first patient has been enrolled in its pivotal...

Aug 28, 2014, 08:00 ET

Celsion to Present at the Rodman & Renshaw 16th Annual Healthcare Conference

 Celsion Corporation (NASDAQ: CLSN), a leading oncology drug development company, today announced that Michael H. Tardugno, Celsion's President...

Aug 07, 2014, 08:00 ET

Celsion Corporation Reports Second Quarter 2014 Financial Results

 Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced financial results for the second quarter ended June...

Jul 31, 2014, 08:00 ET

Celsion Corporation to Hold Second Quarter 2014 Financial Results

 Celsion Corporation (NASDAQ: CLSN) announced today that the Company will host a conference call to discuss its second quarter 2014 financial...

Jul 28, 2014, 08:00 ET

Celsion Announces Updated Overall Survival Data from HEAT Study of ThermoDox® in Primary Liver Cancer

 Celsion Corporation (NASDAQ: CLSN) today announced updated results from its retrospective analysis of the Company's 701-patient HEAT Study of...

Jul 24, 2014, 08:00 ET

Celsion Announces Positive Interim Data Update from its Phase 2 DIGNITY Study in Breast Cancer

Celsion Corporation (NASDAQ: CLSN) announced today positive interim data from its ongoing open-label Phase 2 DIGNITY Trial of ThermoDox® in...

Jul 21, 2014, 08:00 ET

Celsion Corporation Announces $1 Million NIH, NIBIB - Career Development Award Grant for Glioblastoma Research with ThermoDox® and HIFU

Celsion Corporation (NASDAQ: CLSN), a leading oncology drug development company, announced today that its ongoing collaboration with Dr. Costas...

Jul 15, 2014, 08:00 ET

Celsion Corporation Announces Commercialization of Reagent Products

 Celsion Corporation (NASDAQ: CLSN), a leading oncology drug development company, today announced initiation of sales of its proprietary...

Jul 14, 2014, 08:00 ET

Celsion Corporation to Ring the NASDAQ Stock Market Closing Bell on July 16, 2014

 Celsion Corporation (NASDAQ: CLSN), a leading oncology drug development company, announced today that the Company will ring the NASDAQ Stock...

Jun 20, 2014, 09:00 ET

Celsion Corporation Completes Acquisition of EGEN, Inc.

Celsion Corporation (Celsion) (NASDAQ: CLSN), an oncology drug development company, today announced the completion of the acquisition by Celsion of...

Jun 10, 2014, 10:00 ET

Celsion Closes Second $5 Million Tranche under Loan Facility Agreement with Hercules Technology Growth Capital

 Celsion Corporation (NASDAQ: CLSN) today announced that it has closed the second $5 million tranche under its $20 million Loan and Security...

Jun 10, 2014, 07:30 ET

Celsion Corporation to Acquire EGEN, Inc.

 Celsion Corporation (Celsion) (NASDAQ: CLSN), an oncology drug development company, and EGEN, Inc. (EGEN), a privately-held biopharmaceutical...